Neuroinflammation is associated with both early and late stages of the pathophysiology of Alzheimer’s disease (AD). Fluid biomarkers are gaining …
Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease, as some patients progress rapidly toward the more advanced studies, where…
To identify demographic and baseline OCT characteristics that are predictive of VA outcomes after the first and post-loading injections in patients…
To identify diabetic maculopathy features from photographic screening that are predictive of treatment on referral to a tertiary care centre.
Most cancer mutation profiling studies are laboratory-based and lack direct clinical application. For clinical use, it is necessary to focus on key…
Although COVID-19 initially caused great concern about respiratory symptoms, mounting evidence shows that also the pancreas is productively infecte…
Tumor dormancy is a substantial clinical obstacle in treatment of estrogen receptor positive mammary carcinoma (ER+MC), contributing to drug resist…
Huntington’s disease, a neurodegenerative disorder, impairs both upper and lower limb function, typically assessed in clinical settings. However,…
Plasma phospho-tau biomarkers, such as p217+tau, excel at identifying Alzheimer’s disease (AD) neuropathology. However, their ability to substitu…